x

Zoek een klinische studie of trial

* (*) verplicht veld

4 Resultaat/Resultaten

Aanwerving proef = Aanwerving proef
; Lopend onderzoek = Lopend onderzoek
; Terminated trial = Terminated trial							
; Gefinancierd door een IRDiRC-lid = ; Lid van een ERN =

Nationale klinische studie(s)

VERENIGD KONINKRIJK

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

VERENIGD KONINKRIJK

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

VERENIGD KONINKRIJK

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

VERENIGD KONINKRIJK

Tyne & Wear
NEWCASTLE UPON TYNE

MISSING CONTENTAn open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine